Ras antagonist farnesylthiosalicylic acid (FTS) reduces glomerular cellular proliferation and macrophage number in rat Thy-1 nephritis

Journal of the American Society of Nephrology

Volumn 14, Issue 4, 2003, Pages 848-854

  Clarke, Helen C ^a   Kocher, Hemant M ^a   Khwaja, Arif ^a   Kloog, Yoel ^b   Cook, H Terence ^c   Hendry, Bruce M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b TEL AVIV UNIVERSITY   (Israel)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FARNESYLTHIOSALICYLIC ACID; RAS PROTEIN; THY 1 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; EXTRACELLULAR MATRIX; FIBROBLAST; INFLAMMATORY CELL; MACROPHAGE ACTIVATION; MALE; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; RAT; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

EID: 0037377992     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000057543.55318.8B     Document Type: Article

References (25)

1. Couser WG: Pathogenesis of glomerular damage in glomerulonephritis. Nephrol Dial Transplant 13[Suppl 1]: 5-10, 1998
2. Johnson RJ: Cytokines, growth factors and renal injury: Where do we go now? Kidney Int Suppl 63: S2-S6, 1997
3. Norman JT, Fine LF: Progressive renal disease: fibroblasts, extracellular matrix, and integrins. Exp Nephrol 7: 167-177, 1999
4. Bokoch GM, Der, CJ: Emerging concepts in the Ras superfamily of GTP-binding proteins. Faseb J 7: 750-759, 1993
5. Bos JL: p21ras: an oncoprotein functioning in growth factor-induced signal transduction. Eur J Cancer 31A: 1051-1054, 1995
6. Luttrell LM, Daaka Y, Della Rocca GJ, Lefkowitz RJ: G protein-coupled receptors mediate two functionally distinct pathways of tyrosine phosphorylation in rat 1a fibroblasts. Shc phosphorylation and receptor endocytosis correlate with activation of Erk kinases. J Biol Chem 272: 31648-31656, 1997
7. Stacey DW: The ras pathway: A model for the control of proliferation in animal cells. Adv Exp Med Biol 234: 141-167, 1988
8. Sharpe CC, Dockrell ME, Noor MI, Monia BP, Hendry BM: Role of Ras isoforms in the stimulated proliferation of human renal fibroblasts in primary culture. J Am Soc Nephrol 11: 1600-1606, 2000
9. Sharpe CC, Dockrell ME, Noor MI, Monia BP, Hendry BM: Evidence of a role for Ki-Ras in the stimulated proliferation of renal fibroblasts. J Am Soc Nephrol 10: 1186-1192, 1999
10. Khwaja A, Monia BP, Kloog Y, Hendry BM: The inhibition of human mesangial cell proliferation in vitro by targeting Ras GTPases [Abstract]. J Am Soc Nephrol 12: 614A, 2001
11. Aharonson Z, Gana-Weisz M, Varsano T, Haklai R, Marciano D, Kloog Y: Stringent structural requirements for anti-Ras activity of S-prenyl analogues. Biochim Biophys Acta, 1406: 40-50, 1998
12. Haklai R, Weisz MG, Elad G, Paz A, Marciano D, Egozi Y, Ben-Baruch G, Kloog Y: Dislodgment and accelerated degradation of Ras. Biochemistry 37: 1306-1314, 1998
13. Elad G, Paz A, Haklai R, Marciano D, Cox A, Kloog Y: Targeting of K-Ras 4B by S-trans, trans-farnesyl thiosalicylic acid. Biochim Biophys Acta 1452: 228-242, 1999
14. Marom M, Haklai R, Ben-Baruch G, Marciano D, Egozi Y, Kloog Y: Selective inhibition of Ras-dependent cell growth by farnesylthiosalicylic acid. J Biol Chem 270: 22263-22270, 1995
15. Reif S, Weis B, Aeed H, Gana-Weis M, Zaidel L, Avni Y, Romanelli RG, Pinzani M, Kloog Y, Bruck R: The Ras antagonist, farnesylthiosalicylic acid (FTS), inhibits experimentally-induced liver cirrhosis in rats. J Hepatol 31: 1053-1061, 1999
16. Bagchus WM, Jeunink MF, Elema JD: The mesangium in anti-Thy-1 nephritis. Influx of macrophages, mesangial cell hypercellularity, and macromolecular accumulation. Am J Pathol 137: 215-223, 1990
17. Floege J, Eng E, Young BA, Johnson RJ: Factors involved in the regulation of mesangial cell proliferation in vitro and in vivo. Kidney Int Suppl 39: S47-54, 1993
18. Gilbert RE, Kelly DJ, McKay T, Chadban S, Hill PA, Cooper ME, Atkins RC, Nikolic-Paterson DJ: PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis. Kidney Int 59: 1324-1332, 2001
19. Bagchus WM, Hoedemaeker PJ, Rozing J, Bakker WW: Glomerulonephritis induced by monoclonal anti-Thy 1.1 antibodies. A sequential histological and ultrastructural study in the rat. Lab Invest 55: 680-687, 1986
20. Baker FJ, Silverton RE, Luckcock ED: An Introduction to Medical Laboratory Technology, London, Butterworth, 1966
21. Hamilton M, Wolfman A: Ha-ras and N-ras regulate MAPK activity by distinct mechanisms in vivo. Oncogene 16: 1417-1428, 1998
22. Voice JK, Klemke RL, Le A, Jackson JH: Four human ras homologs differ in their abilities to activate Raf-1, induce transformation, and stimulate cell motility. J Biol Chem 274: 17164-17170, 1999
23. Ito Y, Goldschmeding R, Bende R, Claessen N, Chand M, Kleij L, Rabelink T, Weening J, Aten J: Kinetics of connective tissue growth factor expression during experimental proliferative glomerulonephritis. J Am Soc Nephrol 12: 472-484, 2001
24. Blom IE, van Dijk AJ, Wieten L, Duran K, Ito Y, Kleij L, deNichilo M, Rabelink TJ, Weening JJ, Aten J, Goldschmeding R: In vitro evidence for differential involvement of CTGF, TG-Fbeta, and PDGF-BB in mesangial response to injury. Nephrol Dial Transplant 16: 1139-1148, 2001
25. Floege J, Johnson RJ, Gordon K, Iida H, Pritzl P, Yoshimura A, Campbell C, Alpers CE, Couser WG: Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney Int 40: 477-488, 1991